Comparative Effects of Enavogliflozin Versus Dapagliflozin on Adipokines and Leptin Sensitivity in Patients with Type 2 Diabetes: A Pooled Analysis of Phase 3 Trials (ENDO 2026) - Jun 2, 2026 - Abstract #MON-703; Pres time: Jun 15, 2026; 09:00 AM - 02:00 PM; Location: ENDOExpo; Poster Floor; "Enavogliflozin demonstrated a superior reduction in serum leptin levels and a trend toward improved leptin sensitivity compared with dapagliflozin in patients with T2DM."
P3 data • Retrospective data • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus • LEP
|
|
Young Sang Lyu, MD.Phd.; Kyung-Soo Kim, MD, PhD; Hansol Lee, n/a; Sangmo Hong, MD.Phd.
|